An exceptional opportunity to acquire a 70% controlling stake in a state-of-the-art, fully licensed and actively operating dental and aesthetic clinic in the most prestigious area of Lisbon (a prime central location). Situated on an upper floor with stunning panoramic city views, the clinic underwent a premium comprehensive renovation in 2020. This is a turnkey business with an established patient base, a full medical team, and dedicated day-to-day management already in place.
The Asset (CAPEX & Infrastructure):
Premises: 300 sqm of highly optimized, luxurious clinical space.
Clinical Rooms: 7 fully operational treatment rooms equipped with premium-class Ancar dental units (Series 3-5).
High-End Technology: Fotona Laser (approx. 3 years old), Dental Microscope, Intraoral impression scanners, Invisalign scanner, 2x EMS Prophylaxis/Airflow machines, advanced X-ray equipment.
Laboratory Assets Included: A complete suite of high-tech digital dental laboratory equipment (ceramic furnaces, CAD/CAM milling machine, 3D printers, etc.) ready to be deployed.
Licenses: Fully compliant with all active ERS medical licenses.
Team & Operations:
The clinic is actively operating with a complete team of practicing doctors. Day-to-day operations are overseen by a highly dedicated, medically educated manager, ensuring high standards of patient care and immediate operational stability for the new investor from day one.
Financial Overview & Turnaround Opportunity:
- Historical Peak Revenue: 130,000 – 180,000 EUR / month (achieved utilizing only 5 out of 7 rooms).
- Current Revenue: ~30,000 – 50,000 EUR / month.
- The Opportunity: The current drop in revenue was caused by the previous passive involvement of the 30% minority partner. The 70% majority owner, currently residing in the United States, is seeking a clean exit.
By acquiring the 70% majority voting rights, the new investor will gain absolute legal power to support the current operational manager, launch the remaining rooms and lab, sideline the passive minority partner, and easily restore the 1.5M –2.1M+ EUR annual run rate.
